1. Home
  2. BKR vs NTRA Comparison

BKR vs NTRA Comparison

Compare BKR & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baker Hughes Company

BKR

Baker Hughes Company

HOLD

Current Price

$55.56

Market Cap

62.0B

Sector

Industrials

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$406.18

Market Cap

56.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BKR
NTRA
Founded
2016
2003
Country
United States
United States
Employees
64000
N/A
Industry
Metal Fabrications
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.0B
56.7B
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
BKR
NTRA
Price
$55.56
$406.18
Analyst Decision
Buy
Strong Buy
Analyst Count
25
23
Target Price
$71.17
★ $403.89
AVG Volume (30 Days)
★ 5.6M
1.5M
Earning Date
10-27-2026
11-05-2026
Dividend Yield
★ 1.65%
N/A
EPS Growth
★ 56.02
0.65
EPS
★ 2.98
N/A
Revenue
★ $27,733,000,000.00
$210,939,000.00
Revenue This Year
$6.52
$26.19
Revenue Next Year
$10.31
$20.84
P/E Ratio
$18.52
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$44.26
$181.00
52 Week High
$70.41
$437.41

Technical Indicators

Market Signals
Indicator
BKR
NTRA
Relative Strength Index (RSI) 42.33 58.90
Support Level $53.72 $380.39
Resistance Level $58.79 $437.41
Average True Range (ATR) 1.47 17.98
MACD 0.04 -3.92
Stochastic Oscillator 38.63 39.00

Price Performance

Historical Comparison
BKR
NTRA

About BKR Baker Hughes Company

Following a 2022 reorganization, Baker Hughes operates in two segments: oilfield services and equipment, and industrial and energy technology. The firm's oilfield services and equipment segment is one of the Big Three oilfield-services players, along with SLB and Halliburton, and mostly supplies to hydrocarbon developers and producers, including national oil companies, major integrated firms, and independents. Markets outside of North America buy roughly three-fourths of the segment's offerings. Baker Hughes' industrial and energy technology segment manufactures and sells turbines, compressors, pumps, valves, and related testing and monitoring services for various energy and industrial applications.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: